Literature DB >> 2921141

Carcinoma of the urinary bladder category T2,3NXM0 treated by 40 Gy external irradiation followed by cesium137 implant at reduced dose (50%).

B H van der Werf-Messing1, W L van Putten.   

Abstract

Forty-eight bladder cancers T2NXM0 with bad prognostic factors and 42 T3NXM0 growths, suitable for interstitial treatment, were submitted to 40 Gy external irradiation immediately followed by Cae137 Implant at "reduced dose". Intercurrent death corrected 5-year survival for both groups was about 80%. The influence of previously identified bad prognosticators (more than one TUR, WHO grade 3, 4, vascular invasion in the biopsy specimen, pathological IVP) was nearly eradicated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2921141     DOI: 10.1016/0360-3016(89)90332-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004).

Authors:  Robert A Huddart; Emma Hall; Syed A Hussain; Peter Jenkins; Christine Rawlings; Jean Tremlett; Malcolm Crundwell; Fawzi A Adab; Denise Sheehan; Isabel Syndikus; Carey Hendron; Rebecca Lewis; Rachel Waters; Nicholas D James
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-10-01       Impact factor: 7.038

2.  Robot-assisted brachytherapy of the bladder with long distance support using video conferencing.

Authors:  Francisco Mascarenhas; Kris Maes; Fernando Marques; Rui Formoso; Telma Antunes
Journal:  J Contemp Brachytherapy       Date:  2017-08-30

Review 3.  Perpetual role of brachytherapy in organ-sparing treatment for bladder cancer: a historical review.

Authors:  Elzbieta Van der Steen-Banasik; Bernard Oosterveld; Geert Smits; Els Atema; Marion Van Gellekom; Marie Haverkort; Andries Visser
Journal:  J Contemp Brachytherapy       Date:  2020-12-16

Review 4.  Bladder preservation with brachytherapy compared to cystectomy for T1-T3 muscle-invasive bladder cancer: a systematic review.

Authors:  Manouk K Bos; Rafael Ordoñez Marmolejo; Coen R N Rasch; Bradley R Pieters
Journal:  J Contemp Brachytherapy       Date:  2014-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.